302 related articles for article (PubMed ID: 11921625)
21. [Current status of methotrexate].
Fiehn C
Z Rheumatol; 2011 Feb; 70(2):99-100. PubMed ID: 21312022
[No Abstract] [Full Text] [Related]
22. Robin Goodfellow.
Rheumatology (Oxford); 2001 Nov; 40(11):1322. PubMed ID: 11709624
[No Abstract] [Full Text] [Related]
23. Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists.
Gossec L; Bijlsma JW; Bombardier C; Canhão H; Devlin J; Edwards CJ; Hamuryudan V; Kvien TK; Leeb BF; Martín-Mola EM; Mielants H; Müller-Ladner U; Ostergaard M; Pereira IA; Ramos-Remus C; Zochling J; Dougados M
Ann Rheum Dis; 2011 Feb; 70(2):388-9. PubMed ID: 20472594
[No Abstract] [Full Text] [Related]
24. Cyclosporin in pediatric rheumatology; a seven years experience.
Gattinara M; Lomater C; Gerloni V; Mazzotti J; Fantini F
Acta Univ Carol Med (Praha); 1994; 40(1-4):105-8. PubMed ID: 9355683
[No Abstract] [Full Text] [Related]
25. Therapy: A fine conception -- BSR/BHPR guidelines on drugs in pregnancy.
Sammaritano LR; Bermas BL
Nat Rev Rheumatol; 2016 Apr; 12(4):197-8. PubMed ID: 26984054
[TBL] [Abstract][Full Text] [Related]
26. Rheumatic Disease Clinics of North America. Drug safety: managing innovation in rheumatology. Foreword.
Weisman MH
Rheum Dis Clin North Am; 2012 Nov; 38(4):ix-x. PubMed ID: 23137584
[No Abstract] [Full Text] [Related]
27. The possible clinical application of pharmacogenetics in rheumatology.
Ferraccioli G
J Rheumatol; 2003 Dec; 30(12):2517-20. PubMed ID: 14719186
[No Abstract] [Full Text] [Related]
28. Outpatient follow-up for patients with rheumatoid arthritis in relation to New Zealand Rheumatology Association guidelines at Dunedin Hospital.
Chan G; Goh F; Hodgson T; Hsu E; Johnstone D; Ly J; Platt T; Rodrigues E; Tsai W; Hider P; Gray A; Highton J
N Z Med J; 2008 May; 121(1274):34-41. PubMed ID: 18535644
[TBL] [Abstract][Full Text] [Related]
29. [Vaccination recommendations of the Commission for Pharmacotherapy of the German Society of Rheumatology].
Warnatz K; Goldacker S; Gause AM;
Z Rheumatol; 2013 Sep; 72(7):687-9. PubMed ID: 23929238
[No Abstract] [Full Text] [Related]
30. [Cardiovascular risks of Cox-2-antagonists. Opinion on the marketed name rofecoxib, and its market-withdrawn valdecoxib and the actual therapeutic restrictions].
Bolten WW; Reiter S;
Z Rheumatol; 2005 May; 64(4):286-9. PubMed ID: 15909092
[No Abstract] [Full Text] [Related]
31. [Unwanted reactions to modifying antirheumatic drugs].
Evsikova MD; Muraviev IuV
Ter Arkh; 2005; 77(5):72-4. PubMed ID: 15989010
[TBL] [Abstract][Full Text] [Related]
32. [New trends in rheumatology. The Danish Society of Rheumatology].
Andersen LS; Gam AN; Hansen A; Kollerup G; Rasmussen C; Rasmussen JM; Schiøttz-Christensen B; Slot O; Thamsborg G
Ugeskr Laeger; 2003 Mar; 165(12):1255. PubMed ID: 12701305
[No Abstract] [Full Text] [Related]
33. Setting the research agenda for future clinical trials on the use of biologics in rheumatology.
Silman A; Rudkin S; Walley T
Rheumatology (Oxford); 2011 Aug; 50(8):1356-7. PubMed ID: 21118870
[No Abstract] [Full Text] [Related]
34. Drug therapy in adolescents with rheumatic diseases.
Schaller JG
Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):194S-195S. PubMed ID: 9385680
[No Abstract] [Full Text] [Related]
35. Current world literature.
Curr Opin Rheumatol; 2013 May; 25(3):398-409. PubMed ID: 23528992
[No Abstract] [Full Text] [Related]
36. [The use of methotrexate in rheumatology: results and prospects].
Nasonov EL
Klin Med (Mosk); 1996; 74(5):10-5. PubMed ID: 8999172
[No Abstract] [Full Text] [Related]
37. Do rheumatology cost-effectiveness analyses make sense?
Wolfe F; Michaud K; Pincus T
Rheumatology (Oxford); 2004 Jan; 43(1):4-6. PubMed ID: 14523227
[No Abstract] [Full Text] [Related]
38. The role of the British Society for Rheumatology Biologics Register (BSRBR) and the NICE guidelines for anti-TNF therapy.
Watson K; Hyrich K
Musculoskeletal Care; 2003 Mar; 1(1):58-64. PubMed ID: 20217664
[No Abstract] [Full Text] [Related]
39. [Drug-induced agranulocytosis in rheumatology. A retrospective study of 12 cases].
Serraj K; Federici L; Maloisel F; Sibilia J; Andrès E
Ann Biol Clin (Paris); 2007; 65(4):431-6. PubMed ID: 17627927
[TBL] [Abstract][Full Text] [Related]
40. [Continuous quick development of rheumatology].
Madsen OR; Terslev L; Tarp U; Jacobsen S; Ostergaard M
Ugeskr Laeger; 2009 Mar; 171(13):1092. PubMed ID: 19321087
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
